Measure ASD Mod 1

Child looking at digital monitor sitting next to researcher, credit EarliTec.

Measure ASD Mod 1

IRB# 829-23-CB

A Prospective, Multi-Center, Longitudinal Study of Dynamic Quantification of Social-Visual Engagement (DQSVE) For Treatment Monitoring In Children with Autism Spectrum Disorder (ASD) is a research study that seeks to use eye tracking for monitoring treatment progress in kids with ASD.

Eligibility survey

If you are interested in participating in this study, we would like to ask you several short questions to see if you might be eligible. These questions will take about 5 minutes to complete. If you are interested, answer eligibility questions here.

Your child may be eligible for this study if they are/have:
  1. Male or female individuals between the ages of:
    - 15-30 months (chronological age) at the time of consent who have autism spectrum disorder and/or related developmental delays or those who are typically developing.
    - 31-84 months (2.5 - 7 years chronological age) at the time of consent.
  2. Normal or corrected-to-normal vision with visual acuity and oculomotor function sufficient to watch short videos. (Note: Corrective lenses are allowable up to a prescription of +/- 5.0.)
  3. Hearing adequate to hear information presented in age-appropriate videos of social interactions.
  4. For individuals who have autism spectrum disorder and/or related developmental delays, the subject must be established in treatment (e.g., a treatment plan has been developed and child is undergoing treatment or will immediately begin treatment) and intends to remain in treatment continuously throughout the duration of the study. Additionally, individuals must provide a diagnostic report documenting a positive diagnosis of ASD/DD available for review. If a report is not available, subjects must undergo diagnostic evaluation prior to enrolling into the study.
  5. For individuals who are typically developing, the parent, referring clinician and/or daycare center have indicated that the child is not suspected of, nor has he/she exhibited signs of, developmental delays.
Your child may not be eligible for this study if they have:
  1. Severe hearing or visual impairment (e.g., congenital nystagmus, congenital cataracts, previous diagnosis of severe hearing deficits by otoacoustic emissions or auditory brainstem response), which in the opinion of the investigator, would limit the child from completing the EarliPoint eye-tracking procedure or clinical reference assessments.
  2. Subject has an uncontrolled seizure disorder.
  3. Subject is unable or unwilling to undergo DQSVE testing for up to 15 minutes per assessment (e.g., child has frequent tantrums and tantrums do not subside within 5 minutes).
  4. Subject is receiving or plans to receive any investigational drug or device for the duration of this study.

Study details

The research study will require seven (7) visits and will last about 6 months. The first visit will take about 4 hours and additional visits will take about 1 to 3 hours each. During the study visits your child will undergo clinical assessments and/or watch videos on the EarliPointTM.

Evaluation for Autism Spectrum Disorder device. This device will track where your child is looking as they watch the videos. Additionally, we will collect information about medical and developmental history and demographics.

This study is being conducted solely for research purposes and your participation is strictly voluntary. If you are interested in taking part, we will ask you to sign a form to indicate that you consent to taking part in the study. If you consent to participate, you may withdraw from the study at any time. You will receive compensation for participation in each of the study visits.

Email study staff to learn more about the study.

Contact us to learn more

Alice Shillingsburg, PhD, BCBA-D, LP
Professor, Yale Family Endowed Chair
Principal Investigator